vimarsana.com

Page 33 - Dexcom Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Head to Head Survey: enVVeno Medical (NASDAQ:NVNO) versus Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) and enVVeno Medical (NASDAQ:NVNO – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations. Insider and Institutional Ownership 20.1% of […]

Contrasting Tandem Diabetes Care (NASDAQ:TNDM) & enVVeno Medical (NASDAQ:NVNO)

Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) and enVVeno Medical (NASDAQ:NVNO – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability and analyst recommendations. Earnings & Valuation This table compares […]

Clough Capital Partners L P Makes New Investment in DexCom, Inc (NASDAQ:DXCM)

Clough Capital Partners L P acquired a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 107,580 shares of the medical device company’s stock, valued at approximately $10,037,000. DexCom accounts for […]

Abbott Labs Reversal Is Here - CGM Tailwinds In 2024 (NYSE:ABT)

Abbott Labs Reversal Is Here - CGM Tailwinds In 2024 (NYSE:ABT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Dexcom Announces Upcoming Conference Presentation

DexCom, Inc. today announced that Sean Christensen, Vice President, Finance and Investor Relations, will present an update on the company at the 45th Annual Raymond James Institutional Investors.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.